Nurexone Biologic Inc (NRX.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2021 | 09-2021 | 03-2021 | |
| Operating Expenses | 904 | 272 | 96 |
| Operating Income | -904 | -272 | -96 |
| Other Income | -1 | 8 | 0 |
| Pre-tax Income | -905 | -264 | -96 |
| Net Income Continuous | -905 | -264 | -96 |
| Net Income | $-905 | $-264 | $-96 |
| EPS Basic Total Ops | -0.02 | -0.01 | 0.00 |
| EPS Diluted Total Ops | -0.02 | -0.01 | 0.00 |
| EBITDA(a) | $-826 | $-272 | $-96 |